Heilongjiang ZBD Pharmaceutical Co Ltd (603567) - Total Liabilities
Based on the latest financial reports, Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has total liabilities worth CN¥4.36 Billion CNY (≈ $638.27 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of Heilongjiang ZBD Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Heilongjiang ZBD Pharmaceutical Co Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Heilongjiang ZBD Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Heilongjiang ZBD Pharmaceutical Co Ltd total assets.
Heilongjiang ZBD Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Heilongjiang ZBD Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Jinjia Color Printing Group Co Ltd
SHE:002191
|
China | CN¥1.48 Billion |
|
Innova Captab Limited
NSE:INNOVACAP
|
India | Rs7.47 Billion |
|
Barclays PLC
LSE:BARC
|
UK | GBX1.65 Trillion |
|
SGSG Science&technology Co Ltd Zhuhai
SHE:300561
|
China | CN¥67.31 Million |
|
Southern Cable Group Bhd
KLSE:0225
|
Malaysia | RM419.67 Million |
|
Chief Telecom Inc
TWO:6561
|
Taiwan | NT$3.97 Billion |
|
Shenzhen Grandland Decoration Group Co Ltd
SHE:002482
|
China | CN¥2.32 Billion |
|
Obsidian Energy Ltd
TO:OBE
|
Canada | CA$640.40 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Heilongjiang ZBD Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Heilongjiang ZBD Pharmaceutical Co Ltd (603567) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Heilongjiang ZBD Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2025)
The table below shows the annual total liabilities of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥4.36 Billion ≈ $637.29 Million |
-1.50% |
| 2024-12-31 | CN¥4.42 Billion ≈ $647.01 Million |
-0.08% |
| 2023-12-31 | CN¥4.43 Billion ≈ $647.55 Million |
-3.14% |
| 2022-12-31 | CN¥4.57 Billion ≈ $668.53 Million |
+2.55% |
| 2021-12-31 | CN¥4.45 Billion ≈ $651.89 Million |
-5.84% |
| 2020-12-31 | CN¥4.73 Billion ≈ $692.32 Million |
+25.55% |
| 2019-12-31 | CN¥3.77 Billion ≈ $551.45 Million |
+17.81% |
| 2018-12-31 | CN¥3.20 Billion ≈ $468.06 Million |
+44.94% |
| 2017-12-31 | CN¥2.21 Billion ≈ $322.94 Million |
+4.48% |
| 2016-12-31 | CN¥2.11 Billion ≈ $309.10 Million |
+7.33% |
| 2015-12-31 | CN¥1.97 Billion ≈ $288.00 Million |
+37.49% |
| 2014-12-31 | CN¥1.43 Billion ≈ $209.47 Million |
-4.83% |
| 2013-12-31 | CN¥1.50 Billion ≈ $220.09 Million |
+86.07% |
| 2012-12-31 | CN¥808.30 Million ≈ $118.28 Million |
+56.43% |
| 2011-12-31 | CN¥516.70 Million ≈ $75.61 Million |
-- |
About Heilongjiang ZBD Pharmaceutical Co Ltd
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the pharmaceuticals business in China. The company researches, develops, produces, and sale traditional Chinese medicine preparations, biological agents, and chemical agents, as well as involved in the pharmaceutical and Chinese medicinal materials trade; and leasing business. It also engages in pharmaceutical manufacturing; contract manufactur… Read more